Monday, May 20, 2013 Last update: 6:44 AM
Company Tech News as it Breaks
Coyote Pharmaceuticals, Inc.
News articles for Coyote Pharmaceuticals, Inc.:
Wednesday, February 13, 2013
- Coyote Pharmaceuticals Initiates GMP Manufacturing Process for CNS-102 Following Successful Pre-IND MeetingMENLO PARK, Calif., Feb. 13, 2013 /PRNewswire/ -- Coyote Pharmaceuticals, Inc., an emerging biopharmaceutical company focused on neurodegenerative diseases, announced today that it has initiated the GMP manufacturing process for CNS-102 following its recent pre-IND meeting with the Food and Drug Administration (FDA). CNS-102 is ... read more
Wednesday, January 2, 2013
- Coyote Pharmaceuticals to Present at Biotech Showcase(TM) 2013MENLO PARK, Calif., Jan. 2, 2013 /PRNewswire/ -- Coyote Pharmaceuticals, Inc., an emerging biopharmaceutical company focused on neurodegenerative diseases, announced today that President and CEO, Hiroaki Serizawa, Ph.D. will present at the Biotech Showcase(TM) 2013 Conference being held in San Francisco January 7-9, 2013. Dr. Serizawa ... read more